ImmunityBio, Inc.
IBRX
$8.70
$0.495.97%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -5.82% | 67.78% | 149.48% | -58.89% | 14.91% |
| Total Receivables | 26.40% | 50.99% | 27.94% | 557.86% | -45.90% |
| Inventory | -86.42% | 0.95% | -21.36% | 2.08% | 322.47% |
| Prepaid Expenses | -11.38% | 19.98% | 16.35% | -18.59% | 10.01% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -4.65% | 26.86% | 19.90% | 13.12% | -33.54% |
| Total Current Assets | -4.44% | 58.31% | 90.66% | -40.86% | 13.14% |
|
|
|||||
| Total Current Assets | -4.44% | 58.31% | 90.66% | -40.86% | 13.14% |
| Net Property, Plant & Equipment | -9.52% | -2.95% | 0.59% | -2.00% | -2.17% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -3.85% | -3.57% | -3.21% | -3.26% | -3.51% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.71% | 9.76% | -10.22% | 1.30% | 5.11% |
| Total Assets | -3.29% | 29.08% | 32.37% | -20.68% | 5.04% |
|
|
|||||
| Total Accounts Payable | 20.87% | -22.19% | -45.05% | 100.76% | -32.38% |
| Total Accrued Expenses | 6.84% | 16.04% | 32.44% | -33.16% | -3.58% |
| Short-term Debt | -32.73% | -- | -- | -- | -42.30% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.00% | -1.01% | -0.25% | -0.08% | 6.16% |
| Total Finance Division Other Current Liabilities | 65.65% | 9.08% | -28.65% | 117.17% | -42.20% |
| Total Other Current Liabilities | 65.65% | 9.08% | -28.65% | 117.17% | -42.20% |
| Total Current Liabilities | 8.09% | 12.81% | 2.92% | -10.45% | -9.87% |
|
|
|||||
| Total Current Liabilities | 8.09% | 12.81% | 2.92% | -10.45% | -9.87% |
| Long-Term Debt | -1.87% | 2.23% | 2.19% | 4.79% | -23.28% |
| Short-term Debt | -32.73% | -- | -- | -- | -42.30% |
| Capital Leases | -2.03% | -4.77% | 9.05% | -4.96% | -5.27% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -22.10% | 55.70% | 187.37% | -14.51% | -8.43% |
| Total Liabilities | -3.93% | 7.25% | 8.68% | 2.66% | -21.44% |
|
|
|||||
| Common Stock & APIC | 1.97% | 4.02% | 4.17% | 0.30% | 12.22% |
| Retained Earnings | -1.69% | -1.87% | -2.64% | -3.84% | -1.78% |
| Treasury Stock & Other | 479.47% | -60.24% | -37.02% | 1,565.78% | 1,063.11% |
| Total Common Equity | 4.55% | 8.13% | 3.50% | -20.92% | 34.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.55% | 8.13% | 3.50% | -20.92% | 34.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.54% | -2.26% | -2.00% | -2.06% | -1.72% |
| Total Equity | 4.55% | 8.14% | 3.50% | -20.97% | 34.41% |
|
|
|||||